What's happened
Purdue Pharma has agreed to pay up to $7 billion to settle federal and state lawsuits over its role in the opioid crisis. The settlement, approved last year and set to take effect on May 1, requires Sackler family members to contribute most of the funds. Purdue will cease to exist and be replaced by Knoa Pharma.
What's behind the headline?
The Purdue settlement marks a significant shift in holding pharmaceutical companies accountable for the opioid crisis. The $7 billion contribution from the Sackler family aims to fund efforts against overdose deaths, but the reorganization of Purdue into Knoa Pharma complicates legal accountability. This move effectively shields the Sacklers from future lawsuits, which raises questions about justice for victims. The deal’s structure, including Purdue’s dissolution, reflects a broader trend of large-scale corporate settlements designed to address public health crises while limiting ongoing legal exposure. The reorganization could set a precedent for how other companies manage liability in similar cases, but it also risks undermining accountability by removing the original corporate entity from the legal landscape. The settlement’s impact will depend on how effectively the funds are used to combat the epidemic and whether future legal actions are truly prevented.
What the papers say
The Guardian reports that the settlement is among the largest in history, with Sackler family members contributing up to $7 billion over 15 years, and Purdue ceasing operations to be replaced by Knoa Pharma. The Independent emphasizes the legal twists and the complexity of Purdue’s reorganization, highlighting that no Sackler family members have been charged despite their long-standing association with Purdue’s profits. AP News notes that the settlement shields Sackler family members from lawsuits and underscores Purdue’s guilty plea and admitted failures. All sources agree that this settlement represents a major step in addressing the opioid epidemic, but critics question whether it delivers true accountability or merely a financial resolution.
How we got here
The settlement follows Purdue Pharma's guilty plea to federal criminal charges in 2020, admitting to failing to prevent diversion of opioids and engaging in misleading practices. The company’s aggressive marketing of OxyContin in the 1990s has been linked to the rise of the opioid epidemic. The Sackler family, owners of Purdue, have long been criticized for profiting from the crisis, though they have not been charged with crimes.
Go deeper
More on these topics
-
Purdue Pharma L.P. is a privately held pharmaceutical company founded by John Purdue Gray. It is owned principally by descendants of Mortimer and Raymond Sackler.
-
The Sackler family is an American family who owned the pharmaceutical company Purdue Pharma and later founded Mundipharma. Purdue Pharma, and some members of the family, have faced lawsuits regarding over-prescription of addictive pharmaceutical drugs...
-
The United States Department of Justice, also known as the Justice Department, is a federal executive department of the United States government responsible for the enforcement of the law and administration of justice in the United States, and is equivale